Pfizer, BioNTech file patent WO2021213945: Coronavirus vaccine

The present disclosure relates to the fields of packaging, transportation, and storage of temperature-sensitive materials, such as biological and/or pharmaceutical products. Various aspects of such packaging, transportation, and storage are provided herein for ultra-low temperature materials useful for the treatment and/or prevention of disease. The present disclosure also provides packaging materials, methods of transportation, and methods of storage for maintaining biological and/or pharmaceutical materials at ultra-low temperatures in order to maintain the integrity of the materials. The present disclosure further relates to the field of RNA to prevent or treat coronavirus infection.

— Patent WO2021213945A1

Source:

• 
  October 28, 2021. Marjoh NAUTA, Dirk Jozef Peeters, Tom Frank Steven VAN DOORSLAER, Advait Vijay Badkar, Ramin Darvari, Nicholas William Warne, James JEAN, Danny Pierre G. HENDRIKSE, Ugur Sahin, Alptekin GÜLER, Andreas Kuhn, Alexander Muik, Annette VOGEL, Kerstin Walzer, Sonja Witzel, Stephanie HEIN, and Özlem TÜRECI. Coronavirus vaccine. World Intellectual Property Organization WO2021213945A1, filed April 16, 2021, and issued October 28, 2021.
  https://patents.google.com/patent/WO2021213945A1,
  Local copy.
  Patent.

See also, on this site:

• Strange discs are found in vial contents